Pharmacielo Ltd - Asset Resilience Ratio

Latest as of December 2023: 0.00%

Pharmacielo Ltd (PCLO) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CA$0.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

CA$22.29 Million

≈ $16.12 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2023)

This chart shows how Pharmacielo Ltd's Asset Resilience Ratio has changed over time. Check how strategically is Pharmacielo Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Pharmacielo Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Pharmacielo Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$0.00	0%
Total Liquid Assets	CA$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Pharmacielo Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Pharmacielo Ltd Industry Peers by Asset Resilience Ratio

Compare Pharmacielo Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	Drug Manufacturers - Specialty & Generic	1.37%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Celltrion Pharm Inc KQ:068760	Drug Manufacturers - Specialty & Generic	12.49%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Heilongjiang ZBD Pharmaceutical Co Ltd SHG:603567	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Anglikang Pharmaceutical Co Ltd Class A SHE:002940	Drug Manufacturers - Specialty & Generic	9.11%

Annual Asset Resilience Ratio for Pharmacielo Ltd (2019–2023)

The table below shows the annual Asset Resilience Ratio data for Pharmacielo Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.00%	CA$0.00 ≈ $0.00	CA$22.29 Million ≈ $16.12 Million	--
2022-12-31	0.61%	CA$153.00K ≈ $110.68K	CA$25.12 Million ≈ $18.17 Million	-0.20pp
2021-12-31	0.81%	CA$291.00K ≈ $210.50K	CA$35.96 Million ≈ $26.01 Million	-0.89pp
2020-12-31	1.70%	CA$750.05K ≈ $542.57K	CA$44.02 Million ≈ $31.85 Million	+1.49pp
2019-12-31	0.21%	CA$106.00K ≈ $76.68K	CA$50.20 Million ≈ $36.31 Million	--

pp = percentage points

About Pharmacielo Ltd

V:PCLO Canada Drug Manufacturers - Specialty & Generic

Market Cap

$8.84 Million

CA$12.22 Million CAD

Market Cap Rank

#27334 Global

#1146 in Canada

Share Price

CA$0.07

Change (1 day)

+8.33%

52-Week Range

CA$0.04 - CA$0.14

All Time High

CA$11.02